|
New
Release -- Superconductor Week does not edit or endorse the following
news release:
ELEKTA NEUROMAG AND
INNOKAS MEDICAL IN AGREEMENT ON PRODUCTION OUTSOURCING
Stockholm, Sweden, 8 May 2007: Elekta
Neuromag Oy, the Finnish subsidiary of the Swedish Elekta Group, and Innokas
Medical Oy, a Finnish private company, have signed an agreement covering
production of the Elekta Neuromag® magnetoencephalography (MEG) system. The
Elekta Neuromag MEG system is used for non-invasive real-time measurements of
brain activity at leading research institutions and hospitals around the world.
The production, including the employees involved, will be transferred to Innokas
Medical during 2007.
Elekta is reinforcing its operations in the MEG
business area due to the changing market situations and the increased need for
Elekta’s MEG technology. By outsourcing its MEG production to Innokas Medical,
Elekta will get the benefit of a flexible and expert medical equipment
production partner, while keeping the overall technical responsibility of the
MEG system towards the customer. Elekta will continue to invest in innovation
and fulfilling the customers' needs in the MEG area.
For Innokas Medical, this agreement is an important step in its growth strategy.
It will strengthen the company's position as a leading medical equipment
contract manufacturer in Finland.
“Non-invasive, real-time brain mapping and monitoring is considered as one of
the most exciting developments in neuroscience today and the list of new
applications for MEG is steadily growing and the number of installations are
increasing,” said Tomas Puusepp, President and CEO of Elekta. ”Elekta is the
only MEG vendor on the market with the financial stability needed to be
committed to the long-term development of MEG technology and our production
outsourcing agreement with Innokas Medical further strengthen our ability to
serve neuroscience centers around the world with leading MEG technology.”
Return
to industry news releases |
